Cargando…
Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”
Autores principales: | Tang, Ruiqi, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205571/ https://www.ncbi.nlm.nih.gov/pubmed/34211619 http://dx.doi.org/10.1155/2021/9756586 |
Ejemplares similares
-
Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus
por: Tang, Ruiqi, et al.
Publicado: (2021) -
Corrigendum to ‘Plasma concentrations of long chain N-3 fatty acids in early and mid-pregnancy and risk of early preterm birth’
por: S.F., Olsen, et al.
Publicado: (2020) -
Corrigendum to “Impact of Diabetic Ketoacidosis on Thyroid Function in Patients with Diabetes Mellitus”
por: Xing, Yuling, et al.
Publicado: (2021) -
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
Publicado: (2017) -
Corrigendum to “Islet β-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest”
por: Mellado-Gil, Jose Manuel, et al.
Publicado: (2019)